Current Standards for Treatment of Stroke: Management of Acute Ischemic Stroke by Castaldo, John E, MD
Lehigh Valley Health Network
LVHN Scholarly Works
Neurology Update for the Non-Neurologist 2013 Neurology Update for the Non-Neurologist
Feb 21st, 7:00 PM - 7:30 PM
Current Standards for Treatment of Stroke:
Management of Acute Ischemic Stroke
John E. Castaldo MD
Lehigh Valley Health Network, John.Castaldo@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/
neurology_update_non_neurologist
Part of the Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons,
Nervous System Diseases Commons, Neurology Commons, and the Neurosciences Commons
This Presentation is brought to you for free and open access by the Conferences and Symposia Collection at LVHN Scholarly Works. It has been
accepted for inclusion in Neurology Update for the Non-Neurologist by an authorized administrator of LVHN Scholarly Works. For more information,
please contact LibraryServices@lvhn.org.
Castaldo, J. E. (2013). Current Standards for Treatment of Stroke: Management of Acute Ischemic
Stroke. Neurology Update for the Non-Neurologist, . Retrieved from http://scholarlyworks.lvhn.org/
neurology_update_non_neurologist/2013/february_20/5
Current Standards for 
Treatment of Stroke 
 
Management of Acute Ischemic Stroke 
Dr. John Castaldo, MD 
Professor and Chief of Neurology 
© Lehigh Valley Health Network 
Acute Ischemic Stroke 
▪ How big and how bad a problem is it? 
▪ How good are the treatment options? 
• Why don’t we use them more often? 
▪ What are the risks of good therapies? 
• Who should receive these therapies? 
▪ How should we move forward to obtain 
best practice for our communities? 
 
Cerebrovascular Disease:  
Pathogenesis 
Ischemic Stroke (83%) Hemorrhagic Stroke (17%) 
Atherothrombotic  
Cerebrovascular 




(small vessel disease) Other (vasculitis,  
dissection, hypercoagulable,  
Etc. (10%) 
Cryptogenic (5%) 
Subarachnoid Hemorrhage (30%) 
Image(s) have been 
omitted 
How Big and How Bad a Problem 
is Acute Ischemic Stroke? 
Stroke is Very Big and Very Bad 
▪ Happens a lot  
▪ Kills many 
▪ Disables most 
▪ Costs a ton 




▪ Window of RX small 
▪ 800,000/year 
▪ 1 every 3 minutes 
▪ Leading US cause 
▪ $50,000,000,000/year 
▪ 2 million neurons 
▪ 14 billion synapses 
▪ 7.5 miles of axons/ 
min 
▪ Under 4.5 hours/onset 
 
How Good are the Treatment 
Options? 
Preventive and Acute Intervention 
Therapies Work Well (But ….) 
▪ Antihypertensive RX 
▪ Blood glucose 
control 
▪ Afib anticoagulation 
▪ Antiplatelet Rx 
▪ Anti hyperlipidemia 
Rx 
▪  Life Style Change 









▪ Not fun 
Why Don’t More AIS Patients 
Receive Early Restorative 
Treatment? 
Patients Arrive Late 
▪ Mean 155 minutes 




▪ Only 25% 
▪ If using 911 
▪ If first call PCP 
▪ Arrive within 90min 
▪ Arrive within 4hrs 
▪ Actually get tPA 
▪ Know stroke signs 
Stroke Specialists are Rare 
▪ Neurologists / USA 
▪ Vascular boarded 
▪ Hospitals USA 
▪ Total Beds 
▪ JC Primary Stroke 
Centers  
▪ BAC Comprehensive 
▪ Telestroke 
spoke.hub 






▪ 200 anticipated 
▪ Vascular neuro only 
 




Tissue Plasminogen Activator (tPA)  
 
 
Image(s) have been 
omitted 
How Safe and How Effective is 
tPA Anyway? 
How good is tPA in Stroke ? 
▪ Roughly 50% of patients who receive tPA 
within time window leave hospital with 
minimal disability (ranking 0-1) 
▪ Roughly 85% of patients who don’t receive 
tPA are disabled, 15% are dead 
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Comparison 90 Day Outcomes tPA Treated 
LVH to NINDS Study 
IV tPA - Is Safe and It Works 
▪ If 
▪ Pt recognizes signs 
▪ Pt calls 911 
▪ Arrives at a PCS 
▪ Stroke team in 
place 




▪ Few do 
▪ Many call PCP 
▪ Ambulance don’t 
divert 
▪ 24/7 hard to muster 
 
Using tPA in Routine Clinical Practice 
▪ Overall only about 3%-4% of stroke patients receive 
tPA—mostly due to time delays 
▪ Efficacy similar to NINDS trial at most centers 
▪ Rate of ICH: 4%-6% 
▪ Risk of ICH increases with protocol violations 
• Time > 4.5 hours 
• Poor blood pressure control 
• INR > 1.7 
• Recent prior stroke 
• Wrong dose 
– 0.9 mg/kg 
– Maximum dose: 90 mg 
• Elevated age and blood sugar also increases risk 
Time is Brain:  
Benefits of IV tPA Diminish Rapidly 
 3 hr 
Influence of Interval Response to tPA: 
Odds Ratio for Favorable Outcomes 






Post Stent and tPA ICA Stenosis 
Who Should Receive tPA? 
Questions to Ask Before Initiating 
Thrombolytic Therapy 
▪ Did the stroke start within the last 3 hours? 
▪ Any recent illness associated with bleeding risk? 
▪ Is patient taking anticoagulants? 
▪ Are the baseline coagulation tests normal? 
▪ Any medical contraindication for treatment? 
▪ Any neurologic contraindication for treatment? 
▪ What are the findings on CT? 
▪ Are patient and family aware of risks for bleeding? 
▪ What is the blood pressure? 
ACCP 2008 Recommendations: 
Thrombolytic Therapy in AIS 
• For eligible patients, we recommend IV tPA  
0.9 mg/kg (maximum of 90 mg), provided that 
treatment is initiated within 3 hours of clearly 
defined symptom onset (Grade 1A)                
 
• For patients with extensive (greater than 1/3 of 
the MCA territory) and clearly identifiable hypo 
density on CT, we recommend against 
thrombolytic therapy (Grade 1B)  
Treatment of Hypertension During and 
Following Administration of IV tPA 
▪ SBP 180–230 mm Hg or DBP 105–120 mm Hg 
• Labetalol—10 mg IV over 1–2 min 
– Repeat every 10–20 min; maximum dose 300 mg; or 
• Labetalol—10 mg IV followed by infusion 2–8 mg/min 
▪ SBP >230 mm Hg or DBP 121–140 mm Hg 
• Labetalol as above; or 
• Nicardipine—IV infusion at 5 mg/hr 
– Titrate up to desired effect by 2.5 mg/hr every 5 min;                          
maximum rate 15 mg/hr 
▪ DBP >140 mm Hg 
• Nitroprusside infusion 0.5 µg/kg/min; titrate to desired effect 
Goals of Antihypertensive Treatment  
(in search of the Goldilocks BP) 
▪ Too high is bad and may cause bleeding 
▪ Too low may decompensate collaterals and 
extend infarct size 
▪ Lowering too fast is worse than not 
lowering blood pressure at all (unless 
considering tPA) 
▪ In general target 140-180/90-105 
▪ Start with Nicardipene for best results 
What Does Best Practice for AIS 
Look Like in the Age of tPA? 
AIS Treatment: Other Options 
▪ IA administration 
▪ Mechanical thrombolysis 
▪ IA and IV administration 
▪ New thrombolytic agents 
▪ Combination with other antithrombotic 
agents 
▪ Combination with neuroprotective agents 
Thrombolysis:  
IV or IA Approach?  
▪ An IA approach to 
recanalization allows 
for titrated and 
potentially more 
effective 
recanalization vs. IV 
alone  
▪ But takes longer and 
time is brain 
▪ Requires Neuro 
Interventionalist with 
experience 
▪ Delays or eliminates 
window for IV tPA 
which may be fleeting 
▪ Complications 
90-Day Modified Rankin Score 












▪ ACCP 2008 Guidelines for Use of 
Antiplatelet Therapy in Ischemic Stroke 
• In patients not eligible for thrombolytic therapy, early 
Aspirin therapy (160–325 mg/day) is recommended  
(Grade 1A)   
• Delay Aspirin for at least 24 hours after tPA 
• Aspirin can be used safely in combination with low 




▪ Urgent anticoagulation is not recommended  
• Does more harm than good in all studies 
 
▪ Should not be given at all unless imaging has 
excluded hemorrhage 
 
▪ Requires slow initial administration and 
continuous monitoring of anticoagulation and 
adjustments in dose 
Case Presentation (BM) 
▪ 36yo man found down in a pile of mulch 
▪ LVH ED 30 minutes out from discovery 
▪ Stroke Alert : Flaccid quadriplegia, sluggish 
pupils, absent gag, respiratory arrest 
▪ Toes Up going bilaterally 
BM  
Found down unresponsive 
Distal Basilar Artery Occlusion 
Distal Basilar Artery Occlusion 
Interventional Catheter Clot  
Penetration of Basilar Clot 
Basilar Clot Extracted with  
Penumbra Device:  
Image(s) have been 
omitted 
Basilar Occlusion After TPA and Reopro 
Re-cannalization after tPA  
 Cath in SCA 
Basilar Artery: Final Interventional 
Results 
MRI Day 2 Stroke Alert 
MRA Day 2  
Outcome 
▪ NIHSS 0 
▪ Walking the hospital floor unaware of any 
neurological deficits 
▪ Discharged home 
TCD Bubble Study with Valsalva 
(BM) 
On Follow-up 
▪ TEE showed small PFO 
▪ TCD showed aggressive bubble emboli 
▪ Randomized to RESPECT 
▪ Amplatzer device deployed 
▪ Patient has remained free of neurological 
deficits for 2 years 
In a typical acute 
ischemic stroke, every 
minute the brain loses 
 
▪ 1.9 million neurons 
 
▪ 14 billion synapses 
 




   -- Saver, Stroke 2006 
Image(s) have been 
omitted 
Summary AIS Optimal Medical 
Management 2013 
▪ Rapid diagnosis and treatment is crucial to 
outcome: Time is Brain! 
▪ Different strategies are necessary for different 
time windows for IV and IA tPA  
▪ Neuroimaging is opening better understanding of 
tissue at risk/therapeutic outcome with 
aggressive therapy 
▪ Early Risk Factor Modification and Stroke Unit 
improves outcomes substantially 
